MyFinsight
Home
Blog
About
Contact
Download
Download image
Net (loss) income
-$293,423,177
Changes in fair value of
the warrant...
-$45,389,916
Investment income
$948,122
Loss on issuance of
convertible preferred stock...
$321,499,041
Loss from operations
-$15,102,970
Warrant issuance cost
$3,102,649
Foreign exchange losses
-$56,555
Total expenses
$15,102,970
General and
administrative
$9,343,497
Research and development
$5,759,473
Back
Back
Income Statement
source: myfinsight.com
Minerva Neurosciences, Inc. (NERV)
Minerva Neurosciences, Inc. (NERV)